MeSH tree: D06.472
Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication ...
Sep 30, 2026
0
8
Researchers from the International Osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Joint Committee on Bone Metabolism published a study examining self-reported ...
Sep 29, 2026
0
3
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, found no link between semaglutide use and pancreatic cancer in nationwide registry ...
Sep 28, 2026
0
20
As women go through menopause, they often sense that it's not just their bodies changing, but also their minds. They report hot flashes, anxiety, brain fog and trouble sleeping—all symptoms that can be traced back to the ...
Sep 25, 2026
0
45
A new study led by UCLA Health found that a large percentage of disadvantaged patients are not taking their diabetes medications consistently. The analysis of national health records for 587,000 Medicare Advantage patients ...
Sep 24, 2026
0
6
A research team led by Dr. Yangzhi Zhu, principal investigator and assistant professor at the Terasaki Institute for Biomedical Innovation, has developed a soft, reusable smart contact lens as part of its broader Ocular Library ...
Sep 24, 2026
0
7
Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal suggests that this effect cannot be entirely explained by patients losing weight on the drug.
Sep 23, 2026
0
22
Children prescribed GLP-1 medications for weight loss, prediabetes or type 2 diabetes are at risk for nutritional deficiencies—diagnosed in nearly one in six patients (16.8%) within the first year—according to a new study ...
Sep 21, 2026
0
21
GLP-1 drugs have revolutionized obesity treatment, but they can lead people to lose muscle mass along with fat. And when patients stop treatment, they often regain their weight—primarily as fat.
Sep 21, 2026
0
136
Using materials safe for human consumption, MIT researchers have created tiny batteries that could be used to power ingestible electronic devices. Such batteries could make the devices safer for patients and minimize the ...
Sep 21, 2026
0
91
